AGA临床实践更新:炎症性肠病患者的饮食与营养治疗专家综述
美国胃肠病学会(AGA)临床实践更新专家综述,针对临床胃肠病学家提出12条最佳实践建议,涵盖炎症性肠病(IBD)缓解期、活动期及肠衰竭的饮食与营养治疗,并强调营养不良的识别与治疗。该综述基于现有文献与专家意见,非系统综述,未对证据质量或推荐强度进行正式评级。
要点
- 除非有禁忌,所有IBD患者应建议遵循地中海饮食,目前无饮食被一致发现能降低成人IBD复发率。
- 儿童克罗恩病使用全肠内营养诱导缓解的证据强于成人,全肠内营养可考虑作为激素节约的桥接治疗。
- 所有IBD患者应定期筛查营养不良,血清蛋白不再推荐用于营养不良的识别和诊断。
核心结论
- 健康的地中海饮食将使IBD患者受益,但在肠道狭窄或梗阻情况下可能需要调整食物质地。
- 克罗恩病的新数据支持使用肠内液体营养帮助诱导缓解和纠正即将手术患者的营养不良。
- 肠外营养在面临急性和/或慢性肠衰竭的IBD患者中起关键作用。
- 注册营养师是IBD患者最佳营养评估和管理跨学科团队方法的重要组成部分。
研究设计与样本
- 本专家综述由AGA临床实践更新委员会和AGA理事会委托并批准,提供对AGA会员具有高度临床重要性主题的及时指导。
- 经CPU委员会内部同行评审并通过Gastroenterology标准程序进行外部同行评审。
- 最佳实践建议来自对现有文献的回顾结合专家意见,非系统综述,未对证据质量或推荐强度进行正式评级。
主要发现
- 最佳实践建议1:除非有禁忌,所有IBD患者应被建议遵循富含多种新鲜水果蔬菜、单不饱和脂肪、复合碳水化合物和瘦蛋白、低超加工食品、添加糖和盐的地中海饮食以促进整体健康和一般福祉。
- 最佳实践建议1:目前无饮食被一致发现能降低成人IBD复发率;低红肉和加工肉类饮食可能减少溃疡性结肠炎复发,但未发现能减少克罗恩病复发。
- 最佳实践建议2:有症状性肠道狭窄的IBD患者可能因质地而无法耐受纤维性植物性食物(即生水果和蔬菜);强调仔细咀嚼以及将水果蔬菜烹饪和加工至柔软、较少纤维素的稠度可能帮助IBD合并肠道狭窄患者摄入更广泛的植物性食物和纤维。
- 最佳实践建议3:使用液体营养制剂的全肠内营养是诱导克罗恩病临床缓解和内镜应答的有效治疗,儿童证据强于成人;全肠内营养可考虑作为克罗恩病患者的激素节约桥接治疗。
- 最佳实践建议4:克罗恩病排除饮食(一种部分肠内营养治疗)可能是诱导相对短病程轻至中度克罗恩病临床缓解和内镜应答的有效治疗。
关键数值与推荐
- 最佳实践建议5:全肠内营养可能是营养不良的克罗恩病患者择期手术前的有效治疗,以优化营养状态并减少术后并发症。
- 最佳实践建议6:在因腹腔内脓肿和/或蜂窝织炎性炎症而限制通过消化道实现最佳营养的IBD患者中,短期肠外营养可用于术前阶段提供肠道休息以减少感染和炎症,作为确定性手术管理的桥接并优化手术结局。
- 最佳实践建议7:我们建议对高排量胃肠道瘘、延长性肠梗阻、短肠综合征以及口服和肠内营养已尝试并失败或肠内通路不可行或有禁忌的严重营养不良IBD患者使用肠外营养。
- 最佳实践建议8:在IBD合并短肠综合征患者中,长期肠外营养应尽可能过渡到定制水化管理(即静脉电解质支持和/或口服补液溶液)和经口摄入,以降低发生长期并发症的风险;胰高血糖素样肽-2激动剂治疗可促进这一过渡。
- 最佳实践建议9:所有IBD患者应通过评估体征和症状(包括非意愿性体重减轻、水肿和液体潴留以及脂肪和肌肉量丢失)由提供者定期筛查营养不良;当观察到时,表明需要注册营养师进行更完整的营养不良评估;血清蛋白不再推荐用于营养不良的识别和诊断,因其对营养状态缺乏特异性且对炎症高度敏感。
临床怎么用
- 最佳实践建议10:所有IBD患者应监测维生素D和铁缺乏;有广泛回肠病变或既往回肠手术(切除或回肠储袋)的患者应监测维生素B12缺乏。
- 最佳实践建议11:所有门诊和住院的复杂IBD患者均需要与注册营养师共同管理,尤其是那些有营养不良、短肠综合征、肠皮瘘和/或需要更复杂营养治疗(例如肠外营养、肠内营养或全肠内营养)或正在进行克罗恩病排除饮食的患者。
- 最佳实践建议11:我们建议所有新诊断的IBD患者都能获得注册营养师的服务。
- 最佳实践建议12:母乳喂养与儿童期诊断IBD的风险较低相关;富含多种水果蔬菜和减少超加工食品摄入的健康、均衡的地中海饮食与发生IBD的风险较低相关。
局限性
- 本综述非系统综述,未对证据质量或所提出考虑因素的强度进行正式评级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
DESCRIPTION: Diet plays a critical role in human health, but especially for patients with inflammatory bowel disease (IBD). Guidance about diet for patients with IBD are often controversial and a source of uncertainty for many physicians and patients. The role of diet has been investigated as a risk factor for IBD etiopathogenesis and as a therapy for active disease. Dietary restrictions, along with the clinical complications of IBD, can result in malnutrition, an underrecognized condition among this patient population. The aim of this American Gastroenterological Association (AGA) Clinical Practice Update (CPU) is to provide best practice advice statements, primarily to clinical gastroenterologists, covering the topics of diet and nutritional therapies in the management of IBD, while emphasizing identification and treatment of malnutrition in these patients. We provide guidance for tailored dietary approaches during IBD remission, active disease, and intestinal failure. A healthy Mediterranean diet will benefit patients with IBD, but may require accommodations for food texture in the setting of intestinal strictures or obstructions. New data in Crohn's disease supports the use of enteral liquid nutrition to help induce remission and correct malnutrition in patients heading for surgery. Parenteral nutrition plays a critical role in patients with IBD facing acute and/or chronic intestinal failure. Registered dietitians are an essential part of the interdisciplinary team approach for optimal nutrition assessment and management in the patient population with IBD. METHODS: This expert review was commissioned and approved by the AGA Clinical Practice Updates Committee and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership and underwent internal peer review by the CPU Committee and external peer review through standard procedures of Gastroenterology. The best practice advice statements were drawn from reviewing existing literature combined with expert opinion to provide practical advice on the role of diet and nutritional therapies in patients with IBD. Because this was not a systematic review, formal rating of the quality of evidence or strength of the presented considerations was not performed. Best Practice Advice Statements BEST PRACTICE ADVICE 1: Unless there is a contraindication, all patients with IBD should be advised to follow a Mediterranean diet rich in a variety of fresh fruits and vegetables, monounsaturated fats, complex carbohydrates, and lean proteins and low in ultraprocessed foods, added sugar, and salt for their overall health and general well-being. No diet has consistently been found to decrease the rate of flares in adults with IBD. A diet low in red and processed meat may reduce ulcerative colitis flares, but has not been found to reduce relapse in Crohn's disease. BEST PRACTICE ADVICE 2: Patients with IBD who have symptomatic intestinal strictures may not tolerate fibrous, plant-based foods (ie, raw fruits and vegetables) due to their texture. An emphasis on careful chewing and cooking and processing of fruits and vegetables to a soft, less fibrinous consistency may help patients with IBD who have concomitant intestinal strictures incorporate a wider variety of plant-based foods and fiber in their diets. BEST PRACTICE ADVICE 3: Exclusive enteral nutrition using liquid nutrition formulations is an effective therapy for induction of clinical remission and endoscopic response in Crohn's disease, with stronger evidence in children than adults. Exclusive enteral nutrition may be considered as a steroid-sparing bridge therapy for patients with Crohn's disease. BEST PRACTICE ADVICE 4: Crohn's disease exclusion diet, a type of partial enteral nutrition therapy, may be an effective therapy for induction of clinical remission and endoscopic response in mild to moderate Crohn's disease of relatively short duration. BEST PRACTICE ADVICE 5: Exclusive enteral nutrition may be an effective therapy in malnourished patients before undergoing elective surgery for Crohn's disease to optimize nutritional status and reduce postoperative complications. BEST PRACTICE ADVICE 6: In patients with IBD who have an intra-abdominal abscess and/or phlegmonous inflammation that limits ability to achieve optimal nutrition via the digestive tract, short-term parenteral nutrition may be used to provide bowel rest in the preoperative phase to decrease infection and inflammation as a bridge to definitive surgical management and to optimize surgical outcomes. BEST PRACTICE ADVICE 7: We suggest the use of parenteral nutrition for high-output gastrointestinal fistula, prolonged ileus, short bowel syndrome, and for patients with IBD with severe malnutrition when oral and enteral nutrition has been trialed and failed or when enteral access is not feasible or contraindicated. BEST PRACTICE ADVICE 8: In patients with IBD and short bowel syndrome, long-term parenteral nutrition should be transitioned to customized hydration management (ie, intravenous electrolyte support and/or oral rehydration solutions) and oral intake whenever possible to decrease the risk of developing long-term complications. Treatment with glucagon-like peptide-2 agonists can facilitate this transition. BEST PRACTICE ADVICE 9: All patients with IBD warrant regular screening for malnutrition by their provider by means of assessing signs and symptoms, including unintended weight loss, edema and fluid retention, and fat and muscle mass loss. When observed, more complete evaluation for malnutrition by a registered dietitian is indicated. Serum proteins are no longer recommended for the identification and diagnosis of malnutrition due to their lack of specificity for nutritional status and high sensitivity to inflammation. BEST PRACTICE ADVICE 10: All patients with IBD should be monitored for vitamin D and iron deficiency. Patients with extensive ileal disease or prior ileal surgery (resection or ileal pouch) should be monitored for vitamin B12 deficiency. BEST PRACTICE ADVICE 11: All outpatients and inpatients with complicated IBD warrant co-management with a registered dietitian, especially those who have malnutrition, short bowel syndrome, enterocutaneous fistula, and/or are requiring more complex nutrition therapies (eg, parenteral nutrition, enteral nutrition, or exclusive enteral nutrition), or those on a Crohn's disease exclusion diet. We suggest that all newly diagnosed patients with IBD have access to a registered dietitian. BEST PRACTICE ADVICE 12: Breastfeeding is associated with a lower risk for diagnosis of IBD during childhood. A healthy, balanced, Mediterranean diet rich in a variety of fruits and vegetables and decreased intake of ultraprocessed foods have been associated with a lower risk of developing IBD.
引用
- Hashash JG, Elkins J, Lewis JD, et al. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review. Gastroenterology. 2024. PMID: 38276922. doi:10.1053/j.gastro.2023.11.303
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。